Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
US Stock MarketDetailed Quotes
OCUL Ocular Therapeutix
- 8.800
- +0.270+3.17%
Close May 2 16:00 ET
- 8.750
- -0.050-0.57%
Post 20:01 ET
1.40BMarket Cap-7.21P/E (TTM)
8.895High8.490Low1.56MVolume8.640Open8.530Pre Close13.65MTurnover1.25%Turnover RatioLossP/E (Static)159.29MShares11.77552wk High4.44P/B1.09BFloat Cap4.79052wk Low--Dividend TTM124.24MShs Float44.190Historical High--Div YieldTTM4.75%Amplitude1.995Historical Low8.756Avg Price1Lot Size
Ocular Therapeutix Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.03%63.72M | 15.41%17.08M | 2.28%15.43M | 8.26%16.44M | 10.47%14.77M | 13.49%58.44M | 5.16%14.8M | 26.04%15.08M | 23.81%15.19M | 1.42%13.37M |
| Operating revenue | 9.03%63.72M | 15.41%17.08M | 2.28%15.43M | 8.26%16.44M | 10.47%14.77M | 13.49%58.44M | 5.16%14.8M | 26.04%15.08M | 23.81%15.19M | 1.42%13.37M |
| Cost of revenue | 6.53%5.63M | -11.26%1.23M | 13.36%1.56M | 15.72%1.51M | 9.23%1.33M | 16.32%5.28M | 36.96%1.39M | 28.33%1.38M | 12.90%1.3M | -6.62%1.21M |
| Gross profit | 9.28%58.1M | 18.17%15.85M | 1.17%13.86M | 7.56%14.93M | 10.59%13.45M | 13.22%53.16M | 2.69%13.42M | 25.82%13.7M | 24.94%13.88M | 2.30%12.16M |
| Operating expense | 69.60%229.88M | 98.50%66.43M | 81.85%59.86M | 69.87%58.52M | 29.84%45.07M | 7.91%135.54M | 3.21%33.47M | 1.49%32.92M | 11.04%34.45M | 16.79%34.71M |
| Selling and administrative expenses | 37.26%102.24M | 47.30%25.44M | 27.43%22.81M | 53.24%29.67M | 21.88%24.33M | 3.25%74.49M | -8.53%17.27M | -4.37%17.9M | 7.98%19.36M | 20.11%19.96M |
| -Selling and marketing expense | 5.94%5.12M | 15.50%1.32M | 23.98%1.25M | -13.65%1.28M | 5.94%1.27M | 15.89%4.83M | 104.53%1.14M | -90.09%1.01M | -85.40%1.48M | -86.80%1.2M |
| -General and administrative expense | 39.43%97.13M | 49.55%24.12M | 27.63%21.56M | 58.78%28.39M | 22.90%23.06M | 2.47%69.66M | -63.43%16.13M | 97.98%16.89M | 129.59%17.88M | 148.33%18.77M |
| Research and development costs | 109.05%127.64M | 153.10%40.99M | 146.71%37.05M | 91.18%28.86M | 40.60%20.74M | 14.20%61.06M | 19.58%16.2M | 9.48%15.02M | 15.22%15.09M | 12.57%14.75M |
| Operating profit | -108.52%-171.78M | -152.25%-50.58M | -139.40%-46M | -111.91%-43.59M | -40.21%-31.62M | -4.74%-82.38M | -3.56%-20.05M | 10.82%-19.21M | -3.28%-20.57M | -26.45%-22.55M |
| Net non-operating interest income expense | 191.16%6.71M | 158.14%1.57M | 209.71%2.43M | 328.48%2.84M | 89.29%-129K | -18.17%-7.36M | -89.04%-2.69M | -46.43%-2.21M | 23.41%-1.24M | 27.63%-1.21M |
| Non-operating interest income | 409.21%20.28M | 220.15%4.67M | 366.42%5.65M | 706.95%6.04M | 596.63%3.92M | 399.12%3.98M | 244.92%1.46M | 325.26%1.21M | 924.66%748K | 3,027.78%563K |
| Non-operating interest expense | 19.75%13.58M | -25.17%3.11M | -5.90%3.22M | 60.52%3.2M | 129.13%4.05M | 61.46%11.34M | 124.74%4.15M | 90.65%3.43M | 17.39%1.99M | 5.05%1.77M |
| Other net income (expense) | -415.85%-28.43M | 109.62%623K | -66.16%7.08M | -367.64%-3.03M | -404.30%-33.1M | -34.96%9M | -223.56%-6.48M | 1,947.35%20.91M | -59.21%1.13M | -194.36%-6.56M |
| Gain on sale of security | 90.75%-480K | 109.62%623K | 5.27%7.08M | -367.64%-3.03M | 21.50%-5.15M | -137.48%-5.19M | -223.56%-6.48M | 693.29%6.72M | -59.21%1.13M | -194.32%-6.56M |
| Special income (charges) | -296.97%-27.95M | --0 | --0 | --0 | ---27.95M | --14.19M | --0 | --14.19M | --0 | --0 |
| -Less:Other special charges | 296.97%27.95M | --0 | ---- | ---- | --27.95M | ---14.19M | --0 | ---14.19M | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---- | ---- | 0.00%-1K | --0 | ---- | ---- | 50.00%-1K |
| Income before tax | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Income tax | ||||||||||
| Net income | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Net income continuous Operations | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -139.68%-193.51M | -65.60%-48.39M | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M |
| Basic earnings per share | -20.79%-1.22 | 17.14%-0.29 | -2,100.00%-0.22 | 0.00%-0.26 | -25.64%-0.49 | -9.78%-1.01 | -75.00%-0.35 | 96.77%-0.01 | -8.33%-0.26 | -143.75%-0.39 |
| Diluted earnings per share | -19.61%-1.22 | 17.14%-0.29 | 12.00%-0.22 | 0.00%-0.26 | -25.64%-0.49 | -5.15%-1.02 | -45.83%-0.35 | 19.35%-0.25 | -4.00%-0.26 | -77.27%-0.39 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now